Baryon Pharmaceuticals UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
0 |
- |
0 |
0 |
- |
- |
0.00 |
- |
- |
2,500 |
0 |
0 |
2,500 |
2022 |
---|
0 |
0 |
62,556 |
-62,556 |
-41,984 |
- |
-1.10 |
- |
- |
-60,056 |
66,014 |
0 |
5,958 |
2023 |
---|
73,963 |
43,253 |
47,686 |
-47,686 |
-27,887 |
-0.29 |
-2.71 |
-52.46 |
-64.47 |
-21,708 |
58,830 |
0 |
37,122 |
Register and
explore Okredo data2023 |
---|
73,963 |
43,253 |
47,686 |
-47,686 |
-27,887 |
-0.29 |
-2.71 |
-52.46 |
-64.47 |
-21,708 |
58,830 |
0 |
37,122 |
Register and
explore Okredo data2023
Turnover (€)
73,963 €- *
Sales per employee (€)
43,253 €- *
Profit before tax (€)
47,686 €-24 % *
Net Profit (€)
-47,686 €24 % *
Profit per employee (€)
-27,887 €34 % *
Working capital requirement
-0.29 - *
Debt-to-equity ratio
-2.71 -146.36 % *
Total profitability (%)
-52.46 %- *
Net profitability (%)
-64.47 %- *
Equity (€)
-21,708 €64 % *
Amounts Payable And Liabilities (€)
58,830 €-11 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
37,122 €523 % *